| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |